D
Y. Ogiwara et al.
Paper
Synthesis
4-Phenylbenzaldehyde (5)9
LRMS (EI): m/z (%) = 198 (M+, 100), 181 (19), 169 (43), 141 (34), 114
(14), 77 (28).
General procedure was followed with 4-phenylbenzyl alcohol (92.1
mg, 0.5 mmol). Column chromatography (40:1 hexane/EtOAc) afford-
ed 5 as a colorless solid (45.6 mg, 50%); mp 59–60 °C.
4-Hydroxybenzaldehyde (10)13
1H NMR (CDCl3, 500.2 MHz): δ = 7.42 (t, J = 7.5 Hz, 1 H, ArH), 7.48 (t,
J = 7.5 Hz, 2 H, ArH), 7.64 (d, J = 7.5 Hz, 2 H, ArH), 7.76 (d, J = 7.5 Hz, 2
H, ArH), 7.96 (d, J = 7.5 Hz, 2 H, ArH), 10.06 (s, 1 H, CHO).
General procedure was followed with 4-hydroxybenzyl alcohol (62.1
mg, 0.5 mmol). Column chromatography (20:1 hexane/EtOAc) afford-
ed 10 as a colorless solid (51.9 mg, 85%); mp 110–111 °C.
1H NMR (CDCl3, 500.2 MHz): δ = 6.37 (s, 1 H, OH), 6.99 (d, J = 8.5 Hz, 2
H, ArH), 7.83 (d, J = 8.5 Hz, 2 H, ArH), 9.87 (s, 1 H, CHO).
13C NMR (CDCl3, 125.8 MHz): δ = 127.4, 127.7, 128.5, 129.0, 130.3,
135.2 139.7, 147.2, 191.9.
13C NMR (CDCl3, 125.8 MHz): δ = 116.0, 129.8, 132.6, 161.6, 191.3.
LRMS (EI): m/z (%) = 122 (M+, 93), 121 (100), 93 (39), 66 (30).
LRMS (EI): m/z (%) = 182 (M+, 100), 151 (17), 126 (7), 90 (3), 75 (14),
64 (4).
2-Methylbenzaldehyde (6)10
4-(Dimethylamino)benzaldehyde (11)14
General procedure was followed with 2-methylbenzyl alcohol (61.1
mg, 0.5 mmol). Column chromatography (40:1 hexane/EtOAc) afford-
ed 6 as a colorless oil (21.0 mg, 35%).
General procedure was followed with 4-(dimethylamino)benzyl alco-
hol (75.6 mg, 0.5 mmol). Column chromatography (40:1 hexane/EtOAc)
afforded 11 as a colorless solid (52.9 mg, 71%); mp 71–73 °C.
1H NMR (CDCl3, 500.2 MHz): δ = 2.68 (s, 3 H, CH3), 7.26 (d, J = 7.5 Hz, 1
H, ArH), 7.36 (t, J = 7.5 Hz, 1 H, ArH), 7.48 (t, J = 7.5 Hz, 1 H, ArH), 7.80
(d, J = 7.5 Hz, 1 H, ArH), 10.27 (s, 1 H, CHO).
13C NMR (CDCl3, 125.8 MHz): δ = 19.5, 126.3, 131.7, 132.0, 133.6,
134.1, 140.6, 192.8.
1H NMR (CDCl3, 500.2 MHz): δ = 3.09 (s, 6 H, NCH3), 6.71 (d, J = 7.5 Hz,
2 H, ArH), 7.74 (d, J = 7.5 Hz, 2 H, ArH), 9.75 (s, 1 H, CHO).
13C NMR (CDCl3, 125.8 MHz): δ = 40.1, 110.9, 125.1, 132.0, 154.3,
190.3.
LRMS (EI): m/z (%) = 149 (M+, 100), 132 (78), 120 (57), 105 (67), 91
(51), 77 (83), 64 (45).
LRMS (EI): m/z (%) = 120 (M+, 98), 108 (21), 91 (100), 77 (6), 66 (25).
4-Methoxybenzaldehyde (7)10
4-(Methylthio)benzaldehyde (12)3a
General procedure was followed with 4-methoxybenzyl alcohol (69.1
mg, 0.5 mmol). Column chromatography (40:1 hexane/EtOAc) afford-
ed 7 as a colorless oil (54.5 mg, 80%).
General procedure was followed with 4-(methylthio)benzyl alcohol
(77.1 mg, 0.5 mmol). Column chromatography (40:1 hexane/EtOAc)
afforded 12 as a colorless oil (60.8 mg, 80%).
1H NMR (CDCl3, 500.2 MHz): δ = 3.89 (s, 3 H, OCH3), 7.00 (d, J = 8.5 Hz,
2 H, ArH), 7.84 (d, J = 8.5 Hz, 2 H, ArH), 9.88 (s, 1 H, CHO).
13C NMR (CDCl3, 125.8 MHz): δ = 55.5, 114.2, 129.9, 131.9, 164.5,
1H NMR (CDCl3, 500.2 MHz): δ = 2.54 (s, 3 H, SCH3), 7.33 (d, J = 8.5 Hz,
2 H, ArH), 7.78 (d, J = 8.5 Hz, 2 H, ArH), 9.92 (s, 1 H, CHO).
13C NMR (CDCl3, 125.8 MHz): δ = 14.7, 125.2, 130.0, 132.9, 147.9,
190.7.
191.2.
LRMS (EI): m/z (%) = 136 (M+, 100), 107 (33), 92 (36), 77 (66), 66 (19).
LRMS (EI): m/z (%) = 152 (M+, 100), 123 (48), 108 (26), 79 (29), 77
(22), 69 (21), 66 (16).
4-Propoxybenzaldehyde (8)11
General procedure was followed with 4-propoxybenzyl alcohol (83.1
mg, 0.5 mmol). Column chromatography (40:1 hexane/EtOAc) afford-
ed 8 as a colorless oil (68.1 mg, 83%).
1H NMR (CDCl3, 500.2 MHz): δ = 1.53 (t, J = 7.5 Hz, 3 H, CH3), 1.81–
1.88 (m, 2 H, CH2), 4.00 (t, J = 7.0 Hz, 2 H, CH2), 6.99 (d, J = 8.0 Hz, 2 H,
ArH), 7.82 (d, J = 8.0 Hz, 2 H, ArH), 9.87 (s, 1 H, CHO).
13C NMR (CDCl3, 125.8 MHz): δ = 10.4, 22.3, 69.7, 114.7, 129.6, 131.9,
164.2, 190.8.
LRMS (EI): m/z (%) = 164 (M+, 58), 121 (100), 109 (41), 92 (13), 77 (9),
65 (17).
4-Fluorobenzaldehyde (13)15
General procedure was followed with 4-fluorobenzyl alcohol (189.1
mg, 1.5 mmol). Column chromatography (40:1 hexane/EtOAc) afford-
ed 13 as a colorless oil (55.8 mg, 30%).
1H NMR (CDCl3, 500.2 MHz): δ = 7.21–7.24 (m, 2 H, ArH), 7.91–7.93
(m, 2 H, ArH), 9.98 (s, 1 H, CHO).
13C NMR (CDCl3, 125.8 MHz): δ = 116.2 (d, J = 22.0 Hz), 132.1 (d, J = 9.9
Hz), 132.9 (d, J = 2.8 Hz), 166.4 (d, J = 255.1 Hz), 190.4.
LRMS (EI): m/z (%) = 124 (M+, 97), 123 (100), 95 (86), 75 (25).
4-Chlorobenzaldehyde (14)15
3-Phenoxybenzaldehyde (9)12
General procedure was followed with 4-chlorobenzyl alcohol (71.3
mg, 0.5 mmol). Column chromatography (40:1 hexane/EtOAc) afford-
ed 14 as a yellow solid (35.2 mg, 50%); mp 47–49 °C.
1H NMR (CDCl3, 500.2 MHz): δ = 7.52 (d, J = 8.5 Hz, 2 H, ArH), 7.82–
7.84 (m, 2 H, ArH), 9.99 (s, 1 H, CHO).
13C NMR (CDCl3, 125.8 MHz): δ = 129.5, 130.9, 134.7, 140.9, 190.9.
General procedure was followed with 4-phenoxybenzyl alcohol
(100.1 mg, 0.5 mmol). Column chromatography (40:1 hexane/EtOAc)
afforded 9 as a colorless oil (70.3 mg, 71%).
1H NMR (CDCl3, 500.2 MHz): δ = 7.03 (d, J = 8.0 Hz, 2 H, ArH), 7.16 (t,
J = 8.0 Hz, 1 H, ArH), 7.27 (d, J = 8.0 Hz, 1 H, ArH), 7.36 (t, J = 8.0 Hz, 2
H, ArH), 7.50–7.45 (m, 2 H, ArH), 7.59 (d, J = 8.0 Hz, 1 H, ArH), 9.94 (s,
1 H, CHO).
LRMS (EI): m/z (%) = 140 (M+, 93), 139 (100), 113 (22), 110 (66), 77
(17), 75 (30).
13C NMR (CDCl3, 125.8 MHz): δ = 118.0, 119.4, 124.1, 124.5, 124.6,
130.0, 130.4 138.0, 156.1, 158.3, 191.5.
© Georg Thieme Verlag Stuttgart · New York — Synthesis 2016, 48, A–F